60 degrees pharmaceuticals outlines upcoming clinical trial of tafenoquine in babesiosis in letter to journal of infectious diseases

60 degrees pharma plans clinical trial of tafenoquine for babesiosis. letter to journal of infectious diseases outlines protocol. enrollment starts summer.

SXTP Ratings Summary

SXTP Quant Ranking